Skip to content

Vaginal progesterone plus cervical pessary for preventing preterm birth

The effectiveness of the combined treatment with vaginal progesterone plus cervical pessary compared to vaginal progesterone monotherapy for the prevention of preterm birth: a randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201603109568N15
Enrollment
144
Registered
2016-03-22
Start date
2014-08-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm delivery. Preterm spontaneous labour with preterm delivery

Interventions

Intervention 1: Intervention Group: Cervical pessary inserted by an obstetrician, between 18-20 weeks of gestation, in an outpatient setting.A vaginal speculum examination was done to determine the ap
Treatment - Devices
Treatment - Drugs
Intervention Group: Cervical pessary inserted by an obstetrician, between 18-20 weeks of gestation, in an outpatient setting.A vaginal speculum examination was done to determine the appropriate size.
Control Group: Patients received 400 mg of vaginal progesterone once daily before going to bed until 37th week of gestation.

Sponsors

Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18-40 years of age; singleton gestation; 18-22 gestational weeks; cervical length of less than 25 millimeters by transvaginal ultrasound; no cervical dilation; no history of any medical illness. Exclusion criteria: : any medical illness upon enrollment; having urogenital infection; major fetal abnormalities; painful regular uterine contractions; placenta previa; ruptured membranes; active vaginal bleeding; history of cone biopsy; refusing to provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Preterm birth before 37 weeks of gestation. Timepoint: monthly, after the intervention, untill 37th week of gestational. Method of measurement: clinical delivery and the time is assessed based on ultrasound imaging.

Secondary

MeasureTime frame
Low birth weight (LBW) delivery. Timepoint: After birth. Method of measurement: weighing scale.;Premature rupture of membranes. Timepoint: after the intervention. Method of measurement: clinical examination.;Chorioamnionitis. Timepoint: after the intervention. Method of measurement: diagnosed based on placental pathology after delivery.;Requirement for NICU admission. Timepoint: after the intervention. Method of measurement: clinical examination.;Fetal or neonatal death rate. Timepoint: after the intervention. Method of measurement: clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar Karbasian

Tehran University of Medical Scienses

nfkarbasian@gmail.com+98 21 2209 5518

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026